Immunotherapy has emerged as a groundbreaking approach in the treatment of various diseases, particularly cancer. Its main premise is to harness the body's immune system to fight off diseases, offering a unique and often more effective alternative to traditional therapies.
Immunotherapy, also known as biologic therapy, involves the use of substances to stimulate or suppress the immune system to help the body fight cancer, infections, and other diseases. Some forms of immunotherapy are also known as targeted therapies because they target specific parts of the immune system.
Immunotherapies can be broadly categorized into active, passive, and hybrid types. Active immunotherapy stimulates the immune system to react against an antigen, while passive immunotherapies involve the administration of immune components, such as antibodies. Hybrid immunotherapies combine these approaches.
Immunotherapy is primarily used in the treatment of cancer, but its potential applications extend much further. It is being explored in the treatment of diseases such as multiple sclerosis, tuberculosis, and HIV/AIDS. The advent of personalized medicine has also opened up opportunities for targeted immunotherapies.
Despite its promise, immunotherapy is not without challenges. Issues such as immune-related adverse events, high costs, and the need for individualized treatment plans pose significant hurdles. However, continuous research and technological advancements promise to address these challenges and expand the scope of immunotherapy.
Immunotherapy represents a significant shift in our approach to treating diseases, with the potential to revolutionize healthcare. As physicians, understanding this dynamic field is essential to provide the best possible care to our patients and navigate the evolving landscape of modern medicine.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation